R

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Vice President/Senior Director - Nonclinical Drug Safety and Toxicology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • A PhD in toxicology or a related discipline and at least 15 years of experience; an equivalent combination of experience and education may be considered.
  • Experience defining and implementing scientifically relevant and compliant nonclinical toxicology strategies and contingency plans for theoretical and identified nonclinical safety issues.
  • A proven track record of interfacing with global regulatory authorities and designing and interpreting safety studies for regulatory submissions, including Investigational New Drug applications and New Drug Applications.
  • Deep knowledge of Food and Drug Administration and European Medicines Agency requirements and guidance for nonclinical safety submissions.
  • Strong written and oral communication and interpersonal skills, with the ability to function effectively in a matrixed environment.

Responsibilities

  • Create a long-term global toxicology strategy aligned with the company’s vision and objectives, including multi-year scientific and operational plans.
  • Lead scientific direction for global regulatory toxicology, including safety pharmacology.
  • Lead scientific direction for safety assessments of discovery and early development programs, aligning with program objectives and regulatory strategies.
  • Oversee toxicology findings and advise project teams and senior management on potential effects on program goals and probability of success.
  • Collaboratively design and implement external in vitro and in vivo toxicity studies required for lead optimization and development candidate selection.
  • Develop strategy, plans, and budgets to manage regulatory in vitro and in vivo toxicity studies required for Investigational New Drug and New Drug Application submissions, including general toxicity, juvenile toxicity, genotoxicity, safety pharmacology, reproductive and developmental toxicity, and carcinogenicity studies.
  • Work with internal research and development leaders and external development partners, consultants, contract research organizations, and approved vendors, balancing quality, timeliness, and cost.
  • Develop and manage all timelines related to the function.
  • Identify and engage toxicology experts, such as consultants, to interpret study results and make recommendations as needed.
  • Communicate toxicity study results to discovery program and development teams, executive management, and the Board of Directors as needed.
  • Actively participate in regulatory meetings.
  • Perform other duties as assigned.

Desired Qualifications

  • Ten years of experience managing and developing a drug safety/toxicology team is preferred.
  • Diplomate of the American Board of Toxicology certification is strongly preferred.

About the Company

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Remix Therapeutics develops medicines for rare diseases by using targeted degradation of mRNA with an oral small molecule. Its lead candidate REM 422 degrades messenger RNA to stop production of disease-causing proteins and is in Phase 1 trials for ACC and AML, with FDA Orphan Drug designation. The company funds R&D through grants, partnerships, and eventual commercialization, leveraging collaborations with larger pharma. Its goal is to deliver safe and effective medicines for rare cancers and genetic disorders by advancing REM 422 and expanding its portfolio to address unmet medical needs.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Remix Therapeutics

See more jobs